Timing of dornase alpha inhalation does not affect the efficacy of an airway clearance regimen in adults with cystic fibrosis: a randomised crossover trial

1995, Standardization of spirometry: 1994 update, American Journal of Respiratory and Critical Care Medicine, 152, 1107, 10.1164/ajrccm.152.3.7663792 Fitzgerald, 2005, A crossover, randomized, controlled trial of dornase alfa before versus after physiotherapy in cystic fibrosis, Pediatrics, 116, 549, 10.1542/peds.2005-0308 Fuchs, 1994, Effect of aerosolized recombinant human DNase on exacerbations of respiratory symptoms and on pulmonary function in patients with cystic fibrosis, New England Journal of Medicine, 331, 637, 10.1056/NEJM199409083311003 Hubbard, 1992, A preliminary study of aerosolized recombinant human deoxyribonuclease I in the treatment of cystic fibrosis, New England Journal of Medicine, 326, 812, 10.1056/NEJM199203193261207 Knudson, 1976, The maximal expiratory flow-volume curve. Normal standards, variability, and effects of age, American Review of Respiratory Disease, 113, 587 Jones, 2010, Dornase alfa for cystic fibrosis, Cochrane Database of Systematic Reviews, 10.1002/14651858.CD001127.pub2 Léger, 1989, A maximal multistage 20-m shuttle run test to predict VO2 max, European Journal of Applied Physiology and Occupational Physiology, 49, 1, 10.1007/BF00428958 Lieberman, 1968, Dornase aerosol effect on sputum viscosity in cases of cystic fibrosis, JAMA, 205, 312, 10.1001/jama.1968.03140310070022 Pryor, 2008, Physiotherapy techniques (Ch 5) Ramsey, 1993, Efficacy and safety of short-term administration of aerosolized recombinant human deoxyribonuclease in patients with cystic fibrosis, American Review of Respiratory Disease, 148, 145, 10.1164/ajrccm/148.1.145 Ryan, 2003, Nebulised antipseudomonal antibiotics for cystic fibrosis, Cochrane Database of Systematic Reviews, 10.1002/14651858.CD001021 Shak, 1990, Recombinant human DNase I reduces the viscosity of cystic fibrosis sputum, Proceedings of the National Academy of Sciences USA, 87, 9188, 10.1073/pnas.87.23.9188 Singh, 1994, Comparison of oxygen uptake during a conventional treadmill test and the shuttle walking test in chronic airflow limitation, European Respiratory Journal, 7, 2016 Smyth, 2003, Prophylactic anti-staphylococcal antibiotics for cystic fibrosis, Cochrane Database of Systematic Reviews, 10.1002/14651858.CD001912 Southern, 2004, Macrolide antibiotics for cystic fibrosis, Cochrane Database of Systematic Reviews, 10.1002/14651858.CD002203.pub2 van der Giessen, 2007, RhDNase before airway clearance therapy improves airway patency in children with CF, Pediatric Pulmonology, 42, 624, 10.1002/ppul.20636 van der Schans, 2000, Chest physiotherapy compared to no chest physiotherapy for cystic fibrosis, Cochrane Database of Systematic Reviews, 10.1002/14651858.CD001401 Wark, 2009, Nebulised hypertonic saline for cystic fibrosis, Cochrane Database of Systematic Reviews, 10.1002/14651858.CD001506.pub3 Wilson, 2007, Is a longer time interval between recombinant human deoxyribonuclease (dornase alfa) and chest physiotherapy better?.: a multi-center, randomized crossover trial, Pediatric Pulmonology, 42, 1110, 10.1002/ppul.20704